Date	Open	High	Low	Close	Volume	Delivery %	20-Day sma	50-Day sma	200-Day sma
13 Mar, 2025	4779.95	4779.95	4681.40	4706.95	72,930	54.40	4682.20	4969.05	5445.50
12 Mar, 2025	4775.00	4805.90	4696.50	4749.40	99,185	56.82	4682.30	4986.50	5448.65
11 Mar, 2025	4610.00	4790.00	4610.00	4777.75	85,295	47.56	4680.00	5002.90	5452.20
10 Mar, 2025	4738.00	4757.00	4608.00	4632.50	1,02,551	56.67	4681.15	5020.05	5455.60
07 Mar, 2025	4730.00	4782.35	4675.05	4738.05	1,86,716	70.47	4707.10	5038.75	5458.95
06 Mar, 2025	4696.50	4780.00	4676.50	4746.20	1,12,602	58.36	4733.00	5053.65	5461.90
05 Mar, 2025	4610.00	4706.75	4572.15	4696.50	2,57,069	62.43	4751.55	5066.90	5465.35

Day High Low Range

Time	Lowest	Highest	Volume
09.30 AM	4711.55	4779.95	9535.00
09.45 AM	4711.55	4779.95	13747.00
10 AM	4711.55	4779.95	16130.00
11 AM	4711.55	4779.95	24883.00
12 PM	4711.05	4779.95	34712.00
1 PM	4710.00	4779.95	41712.00
2 PM	4710.00	4779.95	50879.00
3 PM	4695.00	4779.95	58829.00

Past Performance & Moving Averages

Day’s	Low high range	SMA	Stock performance	Nifty performance
10 DAY	4491.65 - 4805.90	4690.86	5.01%	2.12%
20 DAY	4491.65 - 4806.00	4682.21	3.65%	-1.1%
50 DAY	4491.65 - 5669.90	4969.03	-6.26%	-2.22%
100 DAY	4491.65 - 6250.00	5295.19	-15.51%	-7.45%
200 DAY	4407.05 - 6439.90	5445.52	-16.68%	-9.67%
YTD	4491.65 - 5673.90	4992.35	-14.63%	-4.64%
52 Week	4407.05 - 6439.90	5353.64	-6.19%	-7.3%

PIVOT POINTS

NAME	S4	S3	S2	S1	PIVOT POINTS	R1	R2	R3	R4
CLASSIC	-	4585.90	4641.20	4695.30	4750.60	4804.70	4860.00	4914.10	-
WOODIE‘S	-	-	4640.90	4694.70	4750.30	4804.10	4859.70	-	-
FIBONACCI	-	4641.20	4682.97	4708.81	4750.60	4792.39	4818.23	4860.00	-
CAMARILLA	4689.23	4719.31	4729.34	4739.37	-	4759.43	4769.46	4779.48	4809.57

CPR Levels

LTP: 4706.95

PDH: 4805.90

PDL: 4696.50

| CPR |

BC: 4714.86

P: 4722.77

TC: 4730.67

ALKEM is currently trading Below CPR levels which signifies Bearishness.
Today's CPR is comparatively Average.
Day's opening range is 4711.55 ~ 4779.95.
Price is currently trading Inside the day's opening range.

Trend Analysis

Short term trend: Down

Medium term trend: Not Clear

Long term trend: Not Clear

Key Data

Market cap	Book value	stock p/e	Dividend yield	roce	roe	sales growth (3Y)	face value (3Y)
56328.49 CR.	862.00	32.90	0.77%	19.60%	19.50%	13.00%	2.00

Profile

Founder: Late Samprada Singh

Founded: 1973

Headoffice: Mumbai, Maharashtra

Number of employees: 15000+

Company's product: pharmaceutical generics, formulations, and nutraceuticals

Overview

It is a multinational Pharmaceutical company.
The Company has 43 years of experience in the industry.
26 October 1988:The company name was changed to 'Alkem Laboratories Limited.
It is the 5th largest pharmaceutical Company in India.

Some of the Milestones

1973: Incorporation of the Company.
1978: Established its first plant at Taloja, Maharashtra.
1988: It considered a deemed public limited company.
1992: Initiate its manufacturing facility in Mandwa, Maharashtra. This specific facility converted into an API facility in 2005.
1998: Kachigam manufacturing facility in Gujarat.
2001: Both Startronic Pharmachem Private Limited and Indo Propkem amalgamated with the Company.
2002: Amaliya manufacturing facility in Gujarat.
2003: Research and development facility at Taloja, Maharashtra.
2005: Settled its manufacturing facility in Baddi, Himachal Pradesh.
2006: The first drug in the Indian pharmaceutical industry to cross 1,000 million in domestic sales in India. (anti-infective drug Taxim)
2007: Its manufacturing facility located in Kumrek, Sikkim Established.
2008: First ANDA filed in the United States for the drug, Amlodipine
2009: It acquired Pharmacor, a generic pharma company in Australia.
2010: Acquired The PharmaNetwork, LLC, holding company of Ascend Laboratories
2011: Acquired Enzene Biosciences Limited.
2012: An API manufacturing facility in the United States.
2014: It also acquired the Clindac drug.
2015: A formulation manufacturing facility in the United States.

Some of the Achievements

2002: Pharma Business and Technology Excellence Award as 'India's Most Esteemed Pharmaceutical Company.'
2004: Pharma Business and Technology Excellence Award for the successful brand.
2005: Overall Performance for Group B at the 5th Express Pharma Awards
2009: Certificate of appreciation for outstanding export performance supported by the Ministry of Commerce and Industry.
2011: Certificate of 'Formulation Experts' by the Pharmaceuticals Export.
2013: India's most admired pharma company.
2014: 'Clavam' was awarded as the 'Brand of the Year'.
2016: The HR Tech award for Best use of technology in Human Resources by World HRD Congress.

TRADER’S TOOLKIT

NSE STOCKS STATS

Get the Latest IPO updates at NiftyTrader Money

Trend Analysis

Short Term Trend:Down
Medium Term Trend:Not Clear
Long Term Trend:Not Clear

Are you friends with trend?

There is a saying in stock market, “Trend is your best friend“

It means, a good trader doesn‘t place his money against the trend. Many new traders lose money because they are trying to catch trend reversals but seasoned traders wait for a clear trend to emerge before taking the trade in the direction of trend.

DAY TECHNICALS

What is Opening Range Breakout?

An opening range breakout is breaking out of the day‘s range after a stock has moved for some time in a sideways trend. In technical terms, its a breakout from the support and resistance level in an upward or downward trend.

NR7

What is NR7 trading strategy?

Narrow Range trading strategy or NR7 Trading strategy is a breakout based method which assumes that the price of security trends up or down after a brief consolidation in a narrow range.

OPENING PRICE CLUES

Same Open & High - Bearish

How to use Opening Price Clues in your trades?

If the stock has same open and high after it has traded for some time, it implies there was a consistent selling pressure that didn‘t allow the stock to move higher from the opening price. Similarly, if the stock has same open and low price, it implies there was a consistent buying intent that kept the stock price above the opening price.

DAY HIGH LOW RANGE

Time	Lowest	Highest	Volume
09.30 AM	4711.55	4779.95	9535.00
09.45 AM	4711.55	4779.95	13747.00
10 AM	4711.55	4779.95	16130.00
11 AM	4711.55	4779.95	24883.00
12 PM	4711.05	4779.95	34712.00
1 PM	4710.00	4779.95	41712.00
2 PM	4710.00	4779.95	50879.00
3 PM	4695.00	4779.95	58829.00

Japanese Candlestick Patterns

Candle Pattern 1: None

Candle Pattern 2: None

Candle Pattern 3: None

Candlestick Price Action

Lower High Lower Low

PIVOT POINTS

NAME	S4	S3	S2	S1	PIVOT POINTS	R1	R2	R3	R4
CLASSIC	-	4585.90	4641.20	4695.30	4750.60	4804.70	4860.00	4914.10	-
WOODIE‘S	-	-	4640.90	4694.70	4750.30	4804.10	4859.70	-	-
FIBONACCI	-	4641.20	4682.97	4708.81	4750.60	4792.39	4818.23	4860.00	-
CAMARILLA	4689.23	4719.31	4729.34	4739.37	-	4759.43	4769.46	4779.48	4809.57

PAST PERFORMANCE & MOVING AVERAGES

DAY’S	LOW HIGH RANGE	SMA	STOCK PERFORMANCE	NIFTY PERFORMANCE
10 DAY	4491.65 4805.90	4690.86	5.01%	2.12%
20 DAY	4491.65 4806.00	4682.21	3.65%	-1.1%
50 DAY	4491.65 5669.90	4969.03	-6.26%	-2.22%
100 DAY	4491.65 6250.00	5295.19	-15.51%	-7.45%
200 DAY	4407.05 6439.90	5445.52	-16.68%	-9.67%
YTD	4491.65 5673.90	4992.35	-14.63%	-4.64%
52 Week	4407.05 6439.90	5353.64	-6.19%	-7.3%

Why are moving Averages important in technical Analysis?

GAPS ON DAY CHART

No Record Found

INDUSTRY GROWTH RATE

In Last 1 Year the industry has grown by 16.42%

In Last 5 Year the industry has grown by 0.00%

PEER COMPARISON

Sales

COMPANY NAME	2023	2022	2021	2020	2019
ALKEM	9,055	10,634	8,865	8,344	7,357
AUROPHARMA	12,792	23,455	24,775	23,099	19,564
CIPLA	15,791	21,763	19,160	17,132	16,362
DRREDDY	16,962	14,405	19,048	17,517	15,448
SUNPHARMA	20,812	15,586	12,803	32,838	29,066
TOTAL	75,412	85,843	84,651	98,930	87,797

Sales

What is Sales Trend ?

Sales trend is a methodology to understand sales results which helps in understanding the trends of the market over a specific period of time. Sales results are an indicative of the sales patterns followed by the customer over a time period.

Value

Sales in

PROFITABILITY

Value

EPS IN

What is EBITDA Margin & EBIT Margin ?

Corporate accounting is required to adhere to the standards and practices collectively referred to as the generally accepted accounting principles. EBITDA is an excellent way for corporate accountants to start compiling data, but it should not be considered an absolute result. This is due to the fact that many consider EBITDA more of a broad stroke than a definitive form of accounting practice.

EBITDA MARGIN IN

EBIT MARGIN IN

NPM IN

CASH FLOW

Why is the Cash Flow Analysis important?

A business needs cash to pay its expenses, to pay bank loans, to pay taxes and to purchase new assets. A cash flow report determines whether a business has enough cash to do exactly this.

Value

Value

Value

FINANCIAL HEALTH

What Is Financial Health?

Financial health is a term used to describe the state of one‘s personal monetary affairs. There are many dimensions to financial health, including the amount of savings you have, how much you’re putting away for retirement, and how much of your income you are spending on fixed or non-discretionary expenses.

Debt to Equity in

PIOTROSKI SCORE

What Is the Piotroski Score?

The Piotroski score is a discrete score between 0-9 that reflects nine criteria used to determine the strength of a firms financial position.

ALTMAN Z SCORE (MFG COMPANY)

Distress (< 1.81)
Caution (>1.81 < 2.99)
4.85
Safe (3 & above)

ALTMAN Z SCORE (NON-MFG COMPANY)

Distress (< 1.23)
Caution (>1.23 < 2.60)
10.06
Safe (2.6 & above)

VALUATION

What Is Valuation?

Valuation is the analytical process of determining the current (or projected) worth of an asset or a company. There are many techniques used for doing a valuation. An analyst placing a value on a company looks at the business's management, the composition of its capital structure, the prospect of future earnings, and the market value of its assets, among other metrics.